Corticosteroids in Severe Community Acquired Pneumonia: Could CAPE COD catalyze a change in critical care management?
REBEL EM
OCTOBER 5, 2023
1-6 We now have the Community-Acquired Pneumonia: Evaluation of Corticosteroids (CAPE COD) Trial. ClinicalTrials.gov: NCT02517489 7 Clinical Question: In adult patients with severe community-acquired pneumonia admitted to the ICU, does early hydrocortisone treatment, compared to standard therapy, reduce mortality at 28 days?
Let's personalize your content